15:43 Nov 19
Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Eris Lifesciences Ltd.
43/100 Medium Financial Strength
Quality22/100 Expensive Valuation
Valuation69/100 Technically Moderately Bullish
TechnicalSWOT
Strength
6
Weakness
3
Opportunity
2
Threat
3
18.63K
Market Cap (Cr)
53.45
PE Ratio
6.65
Price to Book Ratio
55.18
RSI
19.50 %
Net Profit Margin
Rating Based on 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 1452.33 with a high estimate of 1648 and low estimate of 1100
Current 1368.45
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
